𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells

✍ Scribed by Rajani K. Ravi; Martin McMahon; Zang Yangang; Jerry R. Williams; Larry E. Dillehay; Barry D. Nelkin; Mack Mabry

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
438 KB
Volume
72
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Prostate cancer is the most commonly diagnosed neoplasm in men. LNCaP cells continue to possess many of the molecular characteristics of in situ prostate cancer. These cells lack ras mutations, and mitogen-activated protein kinase (MAPK) is not extensively phosphorylated in these cells. To determine the effects of ras/raf/MAPK pathway activation in these cells, we transfected LNCaP cells with an activatable form of c-raf-1(deltaRaf-1:ER). Activation of deltaRaf-1:ER, with resultant MAPK activation, reduced plating efficiency and soft agarose cloning efficiency 30-fold in LNCaP cells. Cell cycle distribution showed an accumulation of cells in G1 and was associated with the induction of CDK inhibitor p21WAF1/CIP1 at the protein and mRNA levels. p21WAF1/CIP1 mRNA stability was increased after deltaRaf-1:ER activation. In addition, activated deltaRaf-1:ER induced the senescence associated-beta-galactosidase in LNCaP cells. These data demonstrate that raf activation can activate growth inhibitory pathways leading to growth suppression in prostate carcinoma cells and also suggest that raf/MEK/MAPK pathway activation, rather than inhibition, may be a therapeutic target for some human prostate cancer cells.

πŸ“œ SIMILAR VOLUMES

STAT3 mediates IL-6-induced growth inhib
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
✍ Spiotto, Michael T.; Chung, Theodore D.K. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 1 views

## BACKGROUND. In prostate cancer, we and others have observed distinct phenotypic responses to interleukin-6 (IL-6), which acts either as a paracrine growth inhibitor in the LNCaP cell line or as an autocrine growth stimulator in PC-3, DU145, and TSU cell lines. To understand the underlying mechan

Ceramide-induced cell death in the prost
Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features
✍ Nikolai Engedal; Fahri Saatcioglu πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 171 KB

BACKGROUND. Prostate cancer is the second leading cause of cancer death in men. The most common treatment of prostate cancer is androgen ablation therapy which leads to regression of the tumor due to increased cell death. However, at later stages, the tumor becomes resistant to androgen ablation. Ce

EGF induces the expression of matrilysin
EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP
✍ Sundareshan, Padma; Nagle, Raymond B.; Bowden, G. Tim πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

BACKGROUND. Matrix metalloproteinases (MMPs) are regulated both positively and negatively at the transcriptional level by a variety of growth factors, oncogenes, and tumor promoters. Induction of the MMP, matrilysin, by epidermal growth factor (EGF) was investigated in a human prostate cancer cell l

Induction of apoptosis by mifepristone a
Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture
✍ El Etreby, M. Fathy; Liang, Yayun; Lewis, Ronald W. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 2 views

data indicate that antiprogestins and antiestrogens could inhibit prostate cancer cell growth in vitro and in vivo. The main objective of the present studies was to explore the role of bcl 2 and TGF␀ 1 for induction of apoptosis in LNCaP prostate cancer cells growing in culture as a treatment respon